Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1600 of 2529 entries
View as:

Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.

Phase: N/A Priority: Normal
NCT ID: NCT00170911 Org: User:
Start: 03/31/05 End: - Due: -

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01156415 Org: User:
Start: 06/30/10 End: 10/31/11 Due: 10/31/12

Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients

Phase: N/A Priority: Normal
NCT ID: NCT00311753 Org: User:
Start: 02/28/06 End: - Due: -

Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%

Phase: N/A Priority: Normal
NCT ID: NCT00101673 Org: User:
Start: 03/31/04 End: 06/30/05 Due: 06/30/06

Efficacy and Safety Study of QVA149 in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02487446 Org: User:
Start: 07/28/15 End: 09/12/16 Due: 09/12/17

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01039376 Org: User:
Start: 05/06/10 End: 06/26/18 Due: 06/26/19

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

Phase: N/A Priority: Normal
NCT ID: NCT02721966 Org: User:
Start: 10/03/16 End: 06/26/19 Due: 06/26/20

A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)

Phase: N/A Priority: Normal
NCT ID: NCT04237116 Org: User:
Start: 02/19/20 End: 07/23/21 Due: 07/23/22

Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter.

Phase: N/A Priority: Normal
NCT ID: NCT05330286 Org: User:
Start: 04/13/22 End: 08/19/22 Due: 08/19/23

AWARE - Chronic Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT02435238 Org: User:
Start: 09/03/14 End: 09/27/17 Due: 09/27/18

A Study of Nilotinib Versus Imatinib in GIST Patients

Phase: N/A Priority: Normal
NCT ID: NCT00785785 Org: User:
Start: 03/31/09 End: 10/31/14 Due: 10/31/15

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT02563067 Org: User:
Start: 12/03/15 End: 08/02/19 Due: 08/02/20

Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02127697 Org: User:
Start: 03/31/15 End: 05/31/17 Due: 05/31/18

An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations

Phase: N/A Priority: Normal
NCT ID: NCT01646125 Org: User:
Start: 11/23/12 End: 11/04/15 Due: 11/04/16

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT03896152 Org: User:
Start: 04/05/19 End: 02/09/22 Due: 02/09/23

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00584740 Org: User:
Start: 08/31/08 End: 08/31/10 Due: 08/31/11

Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00170859 Org: User:
Start: 08/31/04 End: 12/31/06 Due: 12/31/07

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Phase: N/A Priority: Normal
NCT ID: NCT01491529 Org: User:
Start: 04/30/12 End: 04/30/13 Due: 04/30/14

A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

Phase: N/A Priority: Normal
NCT ID: NCT01804400 Org: User:
Start: 10/31/12 End: 10/31/13 Due: 10/31/14

Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus

Phase: N/A Priority: Normal
NCT ID: NCT02338609 Org: User:
Start: 12/17/14 End: 12/18/23 Due: 12/18/24

A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection

Phase: N/A Priority: Normal
NCT ID: NCT01836458 Org: User:
Start: 01/31/14 End: 03/31/15 Due: 03/31/16

Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01365481 Org: User:
Start: 08/31/11 End: 09/30/15 Due: 09/30/16

Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.

Phase: N/A Priority: Normal
NCT ID: NCT01598987 Org: User:
Start: 10/31/12 End: 06/30/16 Due: 06/30/17

Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01660295 Org: User:
Start: 12/31/11 End: - Due: -

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00229138 Org: User:
Start: 09/30/05 End: 03/31/07 Due: 03/31/08